What is Neuren Pharmaceuticals Limited?
Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.10B, and a P/E ratio of 10.5x.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.